Many Americans struggle with heart disease. That’s the conclusion reached in several studies, including one published by the Centers for Disease Control and Prevention (CDC). It revealed that an estimated 695,000 Americans died from heart disease in 2021, accounting for around 1 in 5 deaths. While we are on the topic, it is worth noting that heart disease is not a singular disease. According to the Mayo Clinic, a nonprofit academic medical center in Rochester, Minnesota, heart disease is an umbrella term for numerous conditions that adversely affect the heart. Coronary artery disease, arrhythmias, heart valve disease, and congenital heart defects are some examples of heart disease. Cardiomyopathy and other diseases that affect the heart muscle also fall under that same umbrella.
The Reality of Heart Disease in America: What We Can Learn From Statistical Data
Before taking a deep dive into heart disease statistics in America, let’s take a moment to appreciate the role of this organ in the human body. As part of the circulatory system, the heart pumps blood throughout our body, controls our heart rate, and maintains our blood pressure. As of the writing of this article, coronary artery disease (CAD) is the most commonly diagnosed form of heart disease in the U.S., killing some 375,000 people in 2021 alone. Heart failure and heart attacks take the second place for the most common forms of heart disease.
Study data from the Heart Failure Society of America (HFSA) shows some 960,000 Americans over the age of 20 suffer heart failure annually. In a separate CDC study, researchers revealed that as many as 805,000 Americans suffer a heart attack each year. The same study data also notes that heart disease in general, not only heart failure and heart attacks, are more common among certain racial and ethnic groups than others. Gender also dictates who is most at risk.
Who Is Most at Risk of Being Diagnosed With Heart Disease?
Anyone can develop heart disease, but the risk of that happening is disproportionately higher among some demographics of people. The same applies to those who are most likely to die from the disease. That said, the following are the percentages of all deaths caused by heart disease in 2021 based on ethnicity, race, and sex:
- American Indian or Alaska Native – 15.5%
- Asians – 18.6%
- African Americans – 22.6%
- Pacific Islanders – 18.3%
- Caucasians – 18.0%
- Hispanics – 11.9%
Hispanic women have higher rates of heart disease than men. The same data also notes that heart disease is second only to cancer in terms of prevalence among these demographics of women. What’s more, most of these women are diagnosed with coronary artery disease, with most cases linked to menopause. The hormonal changes associated with menopause heighten a woman’s chances of not only being diagnosed with CAD but also arrhythmia, according to data published by the National Institutes of Health (NIH). Among men and women, the following can increase the risk of heart disease:
- Consuming an unhealthy diet
- Diabetes
- High blood pressure
- High low-density lipoprotein (LDL) cholesterol
- Obesity
- Physical inactivity
- Smoking
The Surprising Benefits of Sermorelin When It Comes to Heart Disease
A growing body of evidence suggests Sermorelin may benefit individuals at risk of or already suffering from heart disease. For those unfamiliar with Sermorelin, it is a peptide hormone structurally similar to growth hormone-releasing hormone in the body. According to its manufacturer, this injectable, synthetic growth hormone-releasing hormone (GHRH) drug triggers the pituitary gland to produce more human growth hormone (HGH), which gets released into the bloodstream. When this happens, it lowers the risk of CAD, arrhythmias, and other common forms of heart disease.
HGH deficiency is associated with metabolic syndrome, an array of interconnected risk factors that increase one’s chances of developing heart disease, such as high blood pressure, high blood sugar, insulin resistance, decreased metabolism, excess body fat, and abnormal cholesterol levels. Sermorelin counters these risk factors by boosting low HGH levels in the body. As a result, those who take it report experiencing increased muscle mass, reduced body fat, improved bone density, more stamina, increased libido, and other notable benefits. Several studies also found that individuals taking the drug struggled less with anxiety and depression.
Sermorelin Results Timeline
Having discussed its many benefits, let’s take a moment to discuss how quickly Sermorelin works. While they might not be instantaneous, it doesn’t take too long to reap the benefits. According to available data, the Sermorelin results timeline is as follows:
Weeks 1 to 2 – During this stage, most people notice subtle changes after starting Sermorelin. The most notable of these include improved sleep quality and more energy.
Weeks 3 to 6 – During this stage, many people on Sermorelin report improvements in focus, mood, and cognitive function. The same applies to early signs of fat loss and increased muscle mass.
After 3 to 6 months, most people notice increased benefits from following a Sermorelin regimen, some of which include the following:
- Deeper and more restful sleep
- Greater strength and performance
- Improvements in mood and overall well-being
- Increased lean muscle mass and reduced body fat
- Increased libido and sexual function
In summary, Sermorelin is a viable treatment for individuals suffering from heart disease triggered by low HGH levels. But that doesn’t necessarily mean it is ideal for everyone living with heart disease. In some cases, traditional HGH hormone replacement therapy consisting of Genotropin, Humatrope, Saizen, or similar drugs might be a better choice. To learn what option is best for you, consider scheduling an appointment with a physician today.
